Name: Wanbury Limited Financial Filings and Reports
Creator: FinancialReports
License: https://financialreports.eu/terms/

Filings indexed 916 across all filing types

Latest filing 2021-09-27 Regulatory Filings

Country IN India

Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing	Released	Lang
Shareholders meeting Regulatory Filings	2021-09-27	English
Pursuant to Regulation 44 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are enclosing herewith the Voting Results of the 33rd Annual General Meeting .... Regulatory Filings	2021-09-27	English
Pursuant to Regulation 44 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are enclosing herewith the Voting Results of the 33rd Annual General Meeting .... Regulatory Filings	2021-09-27	English
Revised summary of proceedings of 33rd Annual General Meeting of Wanbury Limited held on 27th September, 2021. Regulatory Filings	2021-09-27	English
Shareholders meeting Regulatory Filings	2021-09-27	English
Summary of proceedings of 33rd Annual General Meeting of Wanbury Limited held on 27th September, 2021. Regulatory Filings	2021-09-27	English

Browse filings by year

17 years

	ID	Filing	Released	Lang
2021 15 filings
	43186227	Shareholders meeting Regulatory Filings	2021-09-27	English
	46591347	Pursuant to Regulation 44 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are enclosing herewith the Voting Results of the 33rd Annual General Meeting .... Regulatory Filings	2021-09-27	English
	46591350	Pursuant to Regulation 44 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are enclosing herewith the Voting Results of the 33rd Annual General Meeting .... Regulatory Filings	2021-09-27	English
	46591356	Revised summary of proceedings of 33rd Annual General Meeting of Wanbury Limited held on 27th September, 2021. Regulatory Filings	2021-09-27	English
	43189657	Shareholders meeting Regulatory Filings	2021-09-27	English
	46591361	Summary of proceedings of 33rd Annual General Meeting of Wanbury Limited held on 27th September, 2021. Regulatory Filings	2021-09-27	English
	44014609	Board Meeting — Financial Results Regulatory Filings	2021-09-13	English
	46591359	WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2021 ,inter alia, to consider and approve This is with reference to our earlier .... Regulatory Filings	2021-09-13	English
	43138051	Loss of Share Certificates Regulatory Filings	2021-09-09	English
	46591367	We enclose herewith the information regarding loss of share certificates received from a shareholder of the Company pursuant to Regulation 39(3) of the Securities and Exchange Board of .... Regulatory Filings	2021-09-09	English
	43192853	Shareholders meeting Annual Report	2021-09-03	English
	46591370	The 33rct Annual General Meeting (''AGM'') of Wanbury Limited (''the Company'') will be held on Monday, 27th September, 2021, at 11:30 AM through Video Conferencing / Other Audio Visual .... Regulatory Filings	2021-09-03	English
	46591373	The 33rd Annual General Meeting (''AGM'') of Wanbury Limited (''the Company'') will be held on Monday, 27th September, 2021, at 11:30 AM through Video Conferencing / Other Audio Visual .... Regulatory Filings	2021-09-03	English
	43138545	Copy of Newspaper Publication AGM Information	2021-09-02	English
	43138606	Book Closure AGM Information	2021-09-02	English

Page 41 of 62

Prev … 39 40 41 42 43 … Next

Market data

Market data not available

Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products

2,202 peers

Company	Ticker	Country	Sector
13260917 Canada Inc. Biotech developing oral small molecules to restore muscle s…	MSCL	CA	Manufacturing
1608557 Ontario Inc. Biopharmaceutical company dedicated to R&D, discovery, and …	OTROQ	CA	Manufacturing
3B BlackBio Dx Limited Develops molecular diagnostic kits for oncology, infectious…	3BBLACKBIO	IN	Manufacturing
3D Medicines Inc. Commercial-stage biopharma specializing in next-generation …	1244	HK	Manufacturing
3SBio Inc. Biopharmaceutical enterprise specializing in R&D, productio…	1530	KY	Manufacturing
4BASEBIO PLC Manufactures GMP-grade synthetic DNA for next-generation th…	4BB	GB	Manufacturing
4D Molecular Therapeutics, Inc. Develops genetic medicines using AAV vectors for ophthalmol…	FDMT	US	Manufacturing
4Front Ventures Corp. Vertically integrated cannabis operator managing cultivatio…	FFNT	CA	Manufacturing
4SC AG Biopharmaceutical company with no products under developmen…	VSC	DE	Manufacturing
60 DEGREES PHARMACEUTICALS, INC. Develops and commercializes medicines for infectious diseas…	SXTP	US	Manufacturing

Page 1 of 221

1 2 3 … Next

Wanbury Limited via the API

Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.

Get API access Read API reference

Base URLapi.financialreports.eu

Auth headerx-api-key

Company ID60248

TickerWANBURY

ISININE107F01022

Endpoints

most-used routes for this company

GET	/api/companies/60248/	Company identity, sector, listing, identifiers
GET	/api/filings/?company=60248	Paginated list of all filings (filterable by type, date, language)
GET	/api/filings/{id}/	Single filing — metadata, document URL, processing status
GET	/api/filings/{id}/markdown/	Filing content as Markdown (PDF → text/tables/figures)
GET	/api/isins/?company=60248	All ISINs registered to this company
GET	/api/filing-types/	Reference: every filing-type code + category

Full reference: API reference · OpenAPI schema

cURL

latest filings for Wanbury Limited

$ curl https://api.financialreports.eu/api/filings/?company=60248 \
    -H "x-api-key: $FR_API_KEY" \
    -H "Accept: application/json"

Python

requests

import requests

r = requests.get(
    "https://api.financialreports.eu/api/filings/",
    params={"company": 60248},
    headers={"x-api-key": API_KEY},
)
filings = r.json()["results"]

MCP server

Claude · Claude Code · ChatGPT

Claude setup ChatGPT setup Claude Code setup

// MCP server URL
https://mcp.financialfilings.com/mcp

// Once connected, the LLM can query this company directly:
"Pull the latest 5 filings for Wanbury Limited (id: 60248)"

Wanbury Limited — Investor Relations & Filings